Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Emerging Technologies Support the Molecular Basis of the WHO Classification of Hematopoietic Neoplasms].

Rinsho byori. The Japanese journal of clinical pathology - 1 Nov 2014

Miyachi Hayato

Abstract excerpt

In the laboratory diagnosis of hematological neoplasms based on the WHO classification, molecular-genetic testing is indispensable. Emerging technologies for such testing have resulted in a shift of the assay platform from the first generation of a single target for detection or quantitation into advanced multiplex analysis, digital image analysis, automation of measurement, and combination with immunophenotypic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Laboratory Techniques
Share to Exome
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematologic Neoplasms

Share to Molecular Diagnostic Techniques

Share to Molecular Imaging

Share to Oligonucleotide Array Sequence Analysis

Share to World Health Organization

Source

Identifiers

PMID: 27509721

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Emerging Technologies Support the Molecular Basis of the WHO Classification of Hematopoietic Neoplasms].PMID 27509721Read ↗

Changes in the World Health Organization 2016 classification of myeloid neoplasms everyone should know.Semantic proximity Read ↗

Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach.Semantic proximity Read ↗

Molecular Diagnosis of the Hematologic CancersSemantic proximity Read ↗

Molecular Diagnostics of Hematologic MalignanciesSemantic proximity Read ↗

Molecular diagnostics of hematological malignancies.Semantic proximity Read ↗

[Recommendations for laboratory standardization of next generation sequencing in hematological malignancies].Semantic proximity Read ↗

[Molecular diagnosis of leukemia].Semantic proximity Read ↗

The molecular management of classic myeloproliferative neoplasm.Semantic proximity Read ↗

The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.Semantic proximity Read ↗

WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2022 (5th edition): Myeloid and Histiocytic TumorsSemantic proximity Read ↗

Lessons from next-generation sequencing analysis in hematological malignanciesSemantic proximity Read ↗

[NGS-based multi-gene panel testing in hematological malignancies: therapeutic significance].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.